9th European Congress on Lung Disease

September 07, 1999

The 9th annual meeting of the European Respiratory Society (ERS) will be held in Madrid, Spain, this fall. This is the leading gathering of respiratory specialists in Europe. Presentations will be given of the unpublished results of over 3000 studies covering the extremely broad-ranging field of respiratory and lung diseases.

Lung cancer, asthma, chronic bronchitis and sleep apnoea are just some of the topics that will be addressed at this annual Congress.

"It is one of the year's outstanding scientific events", says Nicols Gonzlez Mangado, the chairman of the congress. "This meeting will be a unique, historic occasion, as Spain will be welcoming over 10'000 of the world's leading specialists in respiratory pathology".

Over and above the 3000 advanced studies that have been selected for free communications (either oral presentations or posters), the program includes over 50 specialized symposia featuring the best experts, and covering a range from basic and applied research to still unpublished clinical trials.

"This meeting offers a very attractive combination for a wide audience of specialists, adds Manuel Cosio, the Vice-Chairman of the meeting. That is why the ERS has attracted more and more investigators from all over the world and why our annual meeting is really growing in importance. Madrid got a record number of submitted 3740 abstracts, out of which 3035 were accepted, Manuel Cosio is pleased to report.

One of the symposia, for instance, will be devoted to highly promising new approaches to the prevention of lung cancer. Very recent advances in this field have opened the way to pre-invasive cancer treatment, which stops the formation of cancer cells using an aerosol that will soon undergo human trials. Also in the field of lung cancer, the meeting will be told how it is becoming possible, using sophisticated medical imaging (computerized tomography) techniques, to diagnose the illness at a sufficiently early stage to apply therapy.

Occupational asthma is an issue which is raising an increasing number of questions, to which three more Madrid symposia will be trying to provide some answers. What sort of working conditions, for instance, are more conducive to the disorder, and are some individuals more exposed than others? What are the main risk factors and how much of a problem is absenteeism in different countries? These are the kind of questions the best European and American specialists will be trying to answer.

The 9th ERS annual meeting will also be focussing on artificial ventilation methods. These are techniques intended for patients who need help with their breathing, either because they have been placed in intensive care or because they are seriously affected by chronic respiratory deficiency. One of the symposia will be discussing a worrying problem that has been investigated by a special international task force: certain forms of pneumonia can be caused by the most commonly used method of ventilation, in which the ventilator tube is inserted into the throat. This is even the second most frequent cause of hospital infection.

As if in reply to the results produced so far by that task force, another symposium will for the first time be reporting on large-scale clinical trials undertaken in three European countries on so-called non-invasive ventilation, which consists in blowing air instead through a mask attached over the patients nose and mouth. This method is said to offer many clinical advantages, to save many lives and to work out considerably cheaper.

One of the most popular topics of the meeting, sleep apnoea, will have two major symposia entirely devoted to it for an opportunity to discuss all related issues. For instance, how many individuals are affected by the condition? What sort of health effects can be expected from this nocturnal respiratory disorder, which can even lead to congestive heart failure? What are the implications of ensuing daytime drowsiness, which lies at the root of many accidents? The issues raised will also look at possible medical remedies using well-tried techniques.

The spirit of adventure will not be forgotten at the meeting, since the organizers have decided to extend the agenda to respiratory problems faced by mountaineers, deepsea divers and astronauts. Whether it is on mountain peaks, on the deep sea or out in space, what particular precautions are needed to cope with extreme living conditions?

Apart from those exciting issues, there are other newsworthy topics that could make up some good stories, such as:Again: registration is free for journalists, who will benefit from a modern, fully equipped press center. Embargoed press releases will be available at the meeting. In addition, press conferences will be held every day on very attractive topics, from Monday to Wednesday.

If you would like to attend the meeting, or to receive advance embargoed releases by e-mail (approx. 10 days prior the congress), please send an e-mail to ERS99EK@cedos.int.ch

Don't forget to specify your registration (attending or receiving releases) and please indicate your full name, name of the media, and where you are located (town, country). Thanks.
-end-
Cedos International Centre de documentation et d'information scientifiques

Distribution worldwide of peer reviewed scientific/medical research results

Media contact:Eric Schaerlig

European Respiratory Society

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.